ERS guideline on withdrawal of inhaled corticosteroids in COPD


Chairs: Marc Miravitlles (Barcelona, Spain); Speaker: James Chalmers (Dundee, United Kingdom)

There is frequent inappropriate use of inhaled corticosteroids (ICS) in COPD. ICS are useful in prevention of exacerbations, but an increasing number of patients with mild COPD and infrequent exacerbations are being treated with ICS. The long-term use of ICS is associated with increases risk of side effects, such as pneumonia; therefore, strategies for safe ICS withdrawal are important in clinical practice.